Cognoa

Cognoa is a pioneering company in the field of early childhood development and pediatric behavioral health. One of their breakthrough innovations is Canvas Dx, the first and only FDA-authorized diagnostic solution designed to equip healthcare providers to diagnose or rule out autism in children ages 1.5 to 6 years within days, not months or years. Cognoa uses AI to identify risks for behavioral delays. Their platform employs machine learning technology to determine the most predictive data.